Mumbai (Bombay) 2005

Children and Multidrug-Resistant Tuberculosis in Mumbai (Bombay), India

1360 Emerging Infectious Diseases • Vol. 8, No. 11, November 2002 competent host. Am J Respir Crit Care Med 1999;160:1366–8. 6. Ward MS Lam KV, Cannell PK, Herrmann RP. Mycobacterial central venous catheter tunnel infection: a difficult problem. Bone Marrow Transplant 1999;24:325–9. 7. Telenti A, Marchesi F, Balz M, Bally F, Bottger EC, Bodmer T. Rapid identification of mycobacteria to the spec...

Modified leprosy elimination campaign in Mumbai (Bombay), India--a report.

With appropriate planning and preparation, a modified leprosy elimination campaign (MLEC) was undertaken in Brihan Mumbai (Bombay), which has a population of around 11 million. For the campaign, 4879 non-leprosy paramedical and non-medical personnel were trained and utilized as searchers. The MLEC revealed 1410 new leprosy cases, with a new case detection rate of 1.83/10,000. Over 80% of all ca...

Leptospirosis in Mumbai: post-deluge outbreak 2005.

Indian Institute of Technology , Bombay at TRECVID 2005

This year, Indian Institute of Technology, Bombay participated in TRECVID 2005 in the task of shot detection. We observe that, even though large number of available shot detection methods perform well under normal conditions (as evinced by the results at Trecvid for the last couple of years), they fail when there are deliberate or inadvertent lighting variations. This might result in labeling s...

Evaluation of the activity of CYP2C19 in Gujrati and Marwadi subjects living in Mumbai (Bombay)

BACKGROUND Inherited differences in the metabolism and disposition of drugs, and genetic polymorphisms in the targets of drug therapy (e.g., receptors), can greatly influence efficacy and toxicity of medications. Marked interethnic differences in CYP2C19 (a member of the cytochrome P-450 enzyme superfamily catalyzing phase I drug metabolism) which affects the metabolism of a number of clinicall...